Home › Employers › Pathology Associates of Albuquerque, PA
Pathology Associates of Albuquerque, PA: H-1B salaries and sponsorship
Pathology Associates of Albuquerque, PA filed 4 labor condition applications for H-1B and related visas in fiscal years 2023–2026; certified: 3. Median offered salary: $202,000.
Does Pathology Associates of Albuquerque, PA sponsor H-1B visas?
Pathology Associates of Albuquerque, PA filed 4 labor condition applications in fiscal years 2023–2026, the latest submitted on Jun 1, 2026. An LCA is the first step of an H-1B petition, so the employer has sponsored or prepared to sponsor H-1B workers; it does not guarantee sponsorship for any particular job. Check the employer's own job listings.
Salaries by job title
| Job title | LCAs | Median salary |
|---|---|---|
| Pathologist | 4 | $202,000 |
Applications by fiscal year
| Fiscal year | LCAs | Median salary |
|---|---|---|
| FY2025 | 2 | $202,000 |
| FY2026 | 2 | $250,000 |
Prevailing wage levels
The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.
Where the jobs are
Occupations
Latest applications
| Job title | Base salary | Location | Submitted | Start date | Status |
|---|---|---|---|---|---|
| Pathologist | $250,000 Level II | Albuquerque, NM | Jun 1, 2026 | Jul 1, 2026 | Certified |
| Pathologist | $250,000 Level II | Albuquerque, NM | Jun 1, 2026 | Jul 1, 2026 | Withdrawn |
| Pathologist | $202,000–$250,000 Level I | Albuquerque, NM | Apr 9, 2025 | Jul 31, 2025 | Certified |
| Pathologist | $202,000–$250,000 Level I | Albuquerque, NM | Feb 24, 2025 | Aug 1, 2025 | Certified, then withdrawn |
Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).